In Depth 3 Oct 2017
How Close Are We to Curing ALS? A Review of Biotech’s Efforts
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug in 20 years, when Edaravone/Radicava, developed by Japanese company MT Pharma, received orphan drug registration.…
